Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Immune evasion of tumor cells using membrane-bound complement regulatory proteins
1999
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
2001 Standout
131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients
1999
Survival Differences between Adolescents/Young Adults and Children with B Precursor Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplantation
2012
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)
2002
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Manipulating the Immune System with Immune Globulin
1992
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
LANGERHANS CELL HISTIOCYTOSIS RESEARCH
1998
Trial Watch: Monoclonal antibodies in cancer therapy
2012
Guillain-Barré syndrome
2016 Standout
Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma
2003
Anti-idiotype vaccine against cancer
2000
Steatohepatitis in children
2002
Autoimmunity to Type VII Collagen: Epidermolysis Bullosa Acquisita
2007
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Selection of large diversities of antiidiotypic antibody fragments by phage display
2002 StandoutNobel
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
2010
Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis
1988
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Myasthenia Gravis
1994 Standout
Biology of Natural Killer Cells
1989 Standout
Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
2013
TANGO1 Facilitates Cargo Loading at Endoplasmic Reticulum Exit Sites
2009 StandoutNobel
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
2005 Standout
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases
1991
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia
2003
The microenvironment of the tumour–host interface
2001 StandoutNature
Malignant Gliomas in Adults
2008 Standout
Experience with intravenous immunoglobulin in myasthenia gravis
1989
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
Pregnancy outcome in hematologic malignancies
1991
Hematopoietic Stem-Cell Transplantation
2006 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Bone Marrow Transplantation
1994
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
Neuroblastoma
2007 Standout
Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian Cells
1993
Childhood obesity
2010
Primary brain tumours in adults
2012 Standout
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
2015
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice
2007
Endocrinological late complications after hematopoietic SCT in children
2008
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
The inflammatory reflex
2002 StandoutNature
Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.
1998
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
2002 Standout
Late effects of childhood cancer therapy
2002
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
1999 StandoutNobel
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
2011
Isolating gene-corrected stem cells without drug selection
2005 StandoutNobel
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission
1994
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Transduction of Murine Bone Marrow Cells With an MDR1 Vector Enables Ex Vivo Stem Cell Expansion, but These Expanded Grafts Cause a Myeloproliferative Syndrome in Transplanted Mice
1998
The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin [see comments]
1996
Allele-specific peptide ligand motifs of HLA-C molecules.
1993
Prednisolone Resistance in Childhood Acute Lymphoblastic Leukemia: Vitro-Vivo Correlations and Cross-Resistance to Other Drugs
1998
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Phase II Trial of the Anti-GD2Monoclonal Antibody 3F8 and Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma
2001
Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
1993 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Beyond Neurons: Evidence That Immune and Glial Cells Contribute to Pathological Pain States
2002
In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy
2001
Transduction of Murine Bone Marrow Cells With an MDR1 Vector Enables Ex Vivo Stem Cell Expansion, but These Expanded Grafts Cause a Myeloproliferative Syndrome in Transplanted Mice
1998
Unrelated donor marrow transplantation in children
1995
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
2001 StandoutNobel
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
2008
Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells
2001
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Dinutuximab
2016
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
Final adult height of patients who received hematopoietic cell transplantation in childhood
2004
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
2010 StandoutNobel
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation
1989
Obesity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor Study
2003
Synthesis and in Vitro Multidrug Resistance Modulating Activity of a Series of Dihydrobenzopyrans and Tetrahydroquinolines
1999
Expression of a Functional Eotaxin (CC Chemokine Ligand 11) Receptor CCR3 by Human Dendritic Cells
2002 StandoutNobel
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials
1997
Synergy between an antiangiogenic integrin αvantagonist and an antibody–cytokine fusion protein eradicates spontaneous tumor metastases
1999
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Works of R. Dopfer being referenced
IgG therapy in systemic lupus erythematosus
1984
Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donors
1989
Interferon Gamma Is a Marker for Histiocytosis X Cells in the Skin
1988
Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?
1997
[131I]-Metaiodobenzylguanidine in the treatment of metastatic neuroblastoma
1989
Energy Expenditure, Energy Intake and Prevalence of Obesity after Therapy for Acute Lymphoblastic Leukemia during Childhood
2000
Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark
1994
Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase π gene expression in primary and relapsed state adult and childhood leukaemias
1992
Epidermolysis bullosa acquisita: Efficacy of high-dose intravenous immunoglobulins
1993
Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.
1994
Significant association of acute lymphoblastic leukemia with HLA‐Cw7
1988
CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL—an evaluation of the interferences between morphology and neuropsychological performance
1997
A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a
1992
Clinical Experiences in the Treatment of Neuroblastoma with131I-Metaiodobenzylguanidine
1986
Expression of mdrl, mrp, topoisomerase IIα/β, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias
1995
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma
1995
In Vitro Induction of Lymphokine-Activated Killer (Lak) Activity in Patients with Neuroblastoma
1989
Kinetics of restoration of interferon production after bone marrow transplantation in man.
1987
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study
1991
Pregnancy after bone marrow transplantation for severe aplastic anemia.
1987
Epidermolysis bullosa acquisita: Efficacy of high-dose intravenous immunoglobulins
1994
Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML.
1996
NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
1983
Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood
1999
Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT.
1999
Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83)
1987